Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROFIDYS: Risedronate to reduce bone morbidity in fibrous dysplasia
2006-003549-18Phase 3Completed
- Sponsor
- Cliniques universitaires Saint-Luc
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of risedronate in fibrous dysplasia (2 arms), sponsored by Cliniques universitaires Saint-Luc. Primary endpoint: Intensity of bone pain at the most painful site. Started Aug 2007; status: completed.
02
Drugs
risedronate
03
Conditions
fibrous dysplasia
Beyond the preview
Go deeper on 2006-003549-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003549-18.